南微医学(688029)每日收评(06-30)

Group 1 - The stock of Nanwei Medical (688029) has a comprehensive score of 61.14, indicating a strong performance [1] - The main cost analysis shows that the current main cost is 67.55 yuan, with a 5-day main cost of 66.49 yuan and a 20-day main cost of 65.55 yuan [1][3] - There have been no instances of the stock hitting the upper or lower limits in the past year [1] Group 2 - The technical analysis indicates a short-term resistance level at 67.19 yuan and a support level at 64.10 yuan, suggesting potential for short-term strength if these levels are breached [2] - The K-line pattern shows a "Red Three Soldiers" formation, indicating a possible bottoming out and recovery [2][3] - The net inflow of main funds on June 30, 2025, was 13.31 million yuan, accounting for 16% of the total transaction volume [2][3] Group 3 - The financial data reveals earnings per share of 0.86 yuan and an operating profit of 198 million yuan, with a sales gross margin of 65.689% [2][3] - The net profit reported is approximately 167.16 million yuan [2][3] - The stock is associated with the medical device sector, which has seen a 2.13% increase, and the medical device concept, which has increased by 1.62% [2]